Waterfront Wealth’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,840
| Closed | -$6.82K | – | 265 |
|
|
2024
Q2 | $6.82K | Buy |
2,840
+250
| +10% | +$600 | ﹤0.01% | 245 |
|
|
2024
Q1 | $9.12K | Sell |
2,590
-2,528
| -49% | -$8.91K | ﹤0.01% | 243 |
|
|
2023
Q4 | $21.4K | Sell |
5,118
-1,062
| -17% | -$4.44K | 0.01% | 248 |
|
|
2023
Q3 | $57.8K | Sell |
6,180
-1,434
| -19% | -$13.4K | 0.02% | 244 |
|
|
2023
Q2 | $152K | Buy |
7,614
+445
| +6% | +$8.89K | 0.05% | 246 |
|
|
2023
Q1 | $165K | Buy |
7,169
+125
| +2% | +$2.88K | 0.05% | 238 |
|
|
2022
Q4 | $210K | Sell |
7,044
-1,969
| -22% | -$58.7K | 0.07% | 233 |
|
|
2022
Q3 | $156K | Buy |
9,013
+188
| +2% | +$3.25K | 0.06% | 234 |
|
|
2022
Q2 | $175K | Buy |
8,825
+600
| +7% | +$11.9K | 0.07% | 228 |
|
|
2022
Q1 | $270K | Buy |
8,225
+1,475
| +22% | +$48.4K | 0.1% | 202 |
|
|
2021
Q4 | $302K | Buy |
+6,750
| New | +$302K | 0.12% | 168 |
|